Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-26T03:18:42.838Z Has data issue: false hasContentIssue false
  • English
  • Français

Diagnostic Criteria of Dementia

Published online by Cambridge University Press:  02 December 2014

Rémi W. Bouchard
Rémi W. Bouchard*
Affiliation:
The Clinique de mémoire et unité de recherche Alzheimer, CHA Hôpital de l'Enfant-Jésus, Québec, QC, Canada
*
Clinique de mémoire et unité de recherche Alzheimer, CHA Hôpital de l'Enfant-Jésus, 1401, 18e rue, Québec, Québec, G1J 1Z4, Canada.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In the past two decades there has been a tremendous effort among clinicians and searchers to improve the diagnostic criteria of the dementias on the basis of the differential neurological and neuropsychological profiles. This was an obligatory requirement for clinical trials and the development of treatments. Over the years it became rapidly evident that the cohorts of patients in studies had some degree of heterogeneity, making it difficult to interpret the results of some studies, particularly in the vascular dementias and the mild cognitive impairment (MCI) group. For example, many sub-types of the vascular group were included in clinical trials, such as the cortical strokes, the lacunar states and the diffuse white matter disease cases, and some of the patients might have had also mixed pathology. In addition, the standard DSM IV criteria for dementia no longer represent our present knowledge of the clinical profile of some of the dementias such as vascular dementia (VaD) and fronto-temporal dementia where the memory impairment is not necessarily the first requirement. To improve the validity of clinical trials and eventually help developing more appropriate treatments, we revised the present diagnostic criteria and made recommendations for some changes in the context of the 2nd Canadian Conference on the Development of Antidementia Therapies, held in 2004 and reviewed in the light of the recent literature as of early 2006. It is expected that in the near future, these dementia criteria for clinical trials will have to be revised again in order to include specific subtypes of the dementias as well as biomarkers, structural and functional imaging.

Résumé:

RÉSUMÉ:

Au cours des deux dernières décades, les cliniciens et chercheurs ont fait beaucoup de travail pour améliorer les critères diagnostiques des démences sur la base d'une meilleure connaissance des profils neurologiques et neuropsychologiques. Cela était nécessaire pour les essais cliniques et le développement de nouveaux traitements. Au cours des années il est devenu évident que les patients dans les protocoles de recherche avaient un certain degré d'hétérogénéité qui rendait difficile parfois l'interprétation de certains résultats notamment dans les démences vasculaires et les déficits cognitifs légers. Par exemple dans les études vasculaires, différents sous-groupes étaient inclus dans les études, comme les accidents vasculaires corticaux, les états lacunaires et les atteintes diffuses de la substance blanche et en plus certains des patients pouvaient aussi avoir des pathologies mixtes. De plus les critères classiques de démence selon le DSM IV ne correspondent plus au profil qu'on connaît maintenant des démences vasculaires et des démences fronto-temporales où la mémoire n'est pas nécessairement le premier critère obligatoire. Dans le but d'améliorer la validité des résultats des essais cliniques et éventuellement de développer des traitements appropriés, nous avons révisé les critères actuels des différentes démences et avons recommandé des modifications dans certains critères diagnostiques dans le cadre de la 2e Conférence Canadienne sur le Développement des Traitements de la Démence, tenue en 2004, et également à la lumière de la littérature récente jusqu'à début 2006. Dans un futur non lointain il faut s'attendre à ce que ces critères de démence pour des fins de recherche et d'essai clinique soient à nouveau révisés pour inclure les sous-groupes cliniques, les marqueurs biologiques ainsi que les données d'imagerie structurale et fonctionnelle.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 34 , Issue S1 , March 2007 , pp. S11 - SS18
Copyright
Copyright © The Canadian Journal of Neurological 2007

References

1. Organizing, Committee, Canadian consensus conference on the Assessment of Dementia: the Canadian consensus. Can Med Assoc J. 1991; 144:851–3.Google Scholar
2. American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders, 3rd edn, revised. Washington, DC: American Psychiatric Association (1987).Google Scholar
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association (1994).Google Scholar
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. (IV-TR). Washington, DC: American Psychiatric Association (2000).Google Scholar
5. Lopez, OL, Becker, JT, Klunk, W, Saxton, J, Hamilton, RL, Kaufer, DI, et al. Research evaluation and diagnosis of probable Alzheimer’s disease over the last two decades: pt 1. Neurology. 2000;55:1854–62.CrossRefGoogle Scholar
6. Copeland, MP, Daly, E, Hines, V, Mastromauro, C, Zaitchik, D, Gunther, J, et al. Psychiatric Symptomatology and Prodromal Alzheimer’s Disease. Alzheimer Dis Assoc Disord. 2003; 17:1–8.CrossRefGoogle ScholarPubMed
7. Geerlings, MI, Schmand, B, Braam, AW, Jonker, C, Bouter, LM, van Tilburg, W. Depressive Symptoms and Risk of Alzheimer’s Disease in more Highly Educated Older People. J Am Geriatr Soc. 2000;48:1092–7.CrossRefGoogle ScholarPubMed
8. Lyketsos, CG, Lopez, O, Jones, B, Fitzpatrick, AL, Breitner, J, DeKosky, S. Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment. JAMA. 2002;288:1475–83.CrossRefGoogle ScholarPubMed
9. Knopman, DS, DeKosky, ST, Cummings, JL, Chui, H, Corey-Bloom, J, Relkin, N, et al. Practice parameter: Diagnosis of dementia (an evidence-based review); report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology. 2001; 56:1143–53.CrossRefGoogle Scholar
10. McKhann, G, Drachman, D, Folstein, M, Katzman, R, Price, D, Stadlan, EM. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984; 34:939–44.CrossRefGoogle ScholarPubMed
11. Holmes, C, Cairns, N, Lantos, P, Mann, A. Validity of current clinical criteria for Alzheimer’s disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry. 1999;174:45–50.CrossRefGoogle ScholarPubMed
12. Blacker, D, Albert, MS, Basset, SS, Go, RC, Harrell, LE, Folstein, MF. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer’s disease. The National Institute of Mental Health Genetics Initiative. Arch Neurol. 1994; 51:1198–204.CrossRefGoogle ScholarPubMed
13. Neary, D, Snowden, JS, Gustafson, L, Passant, U, Stuss, D, Black, S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54.CrossRefGoogle ScholarPubMed
14. Feldman, H, Levy, AR, Hsiung, GY, Peters, KR, Donald, A, Black, SE, et al. A Canadian cohort study of cognitive impairment and related dementia (ACCORD): Study methods and baseline results. Neuroepidemiology. 2003; 22:265–74.CrossRefGoogle ScholarPubMed
15. Kertesz, A, Munoz, DG. Primary progressive aphasia and Pick complex. J Neurol Sci. 2003; 206: 97–107.CrossRefGoogle ScholarPubMed
16. The Lund Manchester Groups. Clinical and neuropathological crirteria for Frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1994; 57:416–8.CrossRefGoogle Scholar
17. Miller, BL, Ikonte, C, Ponton, M, Levy, M, Boone, K, Darby, A, et al. A study of the Lund-Manchester research criteria for Frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology. 1997; 46:937–42.CrossRefGoogle Scholar
18. McKhann, G M, Albert Marilyn, S, Grossman, M, Miller, B, Dickson, D, Trojanowski, JQ. Clinical and Pathological Diagnosis of Frontotemporal Dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol. 2001;58:1803–9.CrossRefGoogle Scholar
19. Kertesz, A, Davidson, W, McCabe, P, Takagi, K, Munoz, D. Primary progressive aphasia: diagnosis, varieties, evolution. J Int Neuropsychol Soc. 2003; 9: 710–9.CrossRefGoogle ScholarPubMed
20. Grosman, M. Frontotemporal dementia: a review. J Int Neuropsychol Soc. 2002; 8: 566–83.CrossRefGoogle Scholar
21. Gorno-Tempini, ML, Dronkers, NF, Rankin, KP, Ogar, JM, Phengrasamy, L, Rosen, HJ, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004; 55:335–46.CrossRefGoogle ScholarPubMed
22. McKeith, IG, Dickson, DW, Lowe, J, Emre, M, O’Brien, JT, Feldman, H, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology. 2005;65:1863–72.CrossRefGoogle ScholarPubMed
23. Lopez, OL, Litvan, I, Catt, KE, Stowe, R, Klunk, W, Kaufer, DI, et al. Accuracy of four diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology. 1999;53:1292–9.CrossRefGoogle ScholarPubMed
24. McKeith, IG, Galasko, D, Kosaka, K, Perry, EK, Dickson, DW, Hansen, LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996; 47: 1113–24.CrossRefGoogle Scholar
25. McKeith, IG, Perry, EK, Perry, RH. Report of the second dementia with Lewy body international workshop. Neurology. 1999;53:902–5.CrossRefGoogle ScholarPubMed
26. Korszyn, AD. Dementia in Parkinson’s disease. J Neurol. 2001; 248 (Suppl 3): III/1–III/4.CrossRefGoogle Scholar
27. Mayeux, R, Denaro, J, Hemenegildo, N, Marder, K, Tang, MX, Cote, LJ, et al. A population-based investigation of Parkinson’s disease with and without dementia: relationship to age and gender. Arch Neurol. 1992;49:492–7.CrossRefGoogle ScholarPubMed
28. Aarsland, D, Tandberg, E, Larsen, JP, Cummings, JL. Frequency of dementia in Parkinson’s disease. Arch Neurol. 1996;53:538–42.CrossRefGoogle Scholar
29. Aarsland, D, Andersen, K, Larsen, JP, Lolk, A, Nielsen, H, Kragh-Sorensen, P. Risk of dementia in Parkinson’s disease: a community-based, prospective study. Neurology. 2001;56:730–6.CrossRefGoogle ScholarPubMed
30. Emre, M. Dementia associated with Parkinson’s disease. THE Lancet Neurol. 2003; 2:229–37.CrossRefGoogle ScholarPubMed
31. Boller, F, Mizutani, T, Roessmann, U, Gambetti, P. Parkinson Disease, Dementia, and Alzheimer’s Disease: Clinicopathological Correlations. Ann Neurol. 1980;7:329–35.CrossRefGoogle ScholarPubMed
32. Braak, H, Rüb, U, Jansen Steur, ENH, Del Tredici, K, de Vos, RA. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology. 2005;64:1404–10.CrossRefGoogle ScholarPubMed
33. Leverenz, JB, Fishel, MA, Peskind, ER, Montine, TJ, Nochlin, D, Steinbart, E, et al. Lewy Body Pathology in Familial Alzheimer Disease. Arch Neurol. 2006:63:370–6.CrossRefGoogle ScholarPubMed
34. Erisi, MM, Wilcock, GK, Morris, JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry. 1997;63:749–53.Google Scholar
35. Tomlinson, BE, Blessed, G, Roth, M. Observations on the brain of demented old people. J Neurol Sci. 1970;11:205–42.CrossRefGoogle ScholarPubMed
36. Hansen, LA, Samuel, W. Criteria for Alzheimer’s disease and the nosology of dementia with Lewy bodies. Neurology. 1997;48:126–32.CrossRefGoogle ScholarPubMed
37. Hughes, AJ, Daniel, SE, Blankson, S, Lees, AJ. A clinicopathologic study of 100 cases of Parkinson’s disease. Arch Neurol. 1993;50:140–8.CrossRefGoogle ScholarPubMed
38. McKeith, I, Mintzer, J, Aarsland, D, Burn, D, Chui, H, Cohen-Mansfield, J, et al. Dementia with Lewy bodies. Lancet Neurology. 2004;3:19–28.CrossRefGoogle ScholarPubMed
39. Rogers, RD, Sahakian, BJ, Hodges, JR, Polkey, CE, Kennard, C, Robbins, TW. Dissociating executive mechanisms of task control following frontal lobe and Parkinson’s disease. Brain. 1998;121:815–42.CrossRefGoogle ScholarPubMed
40. Litvan, I, Mohr, E, Williams, J, Gomez, C, Chase, TN. Differential memory and executive functions in demented patients with Parkinson’s and Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 1991;54:25–9.CrossRefGoogle ScholarPubMed
41. Pillon, B, Boller, F, Levy, R, Dubois, B. Cognitive deficits and dementia in Parkinson’s disease. In: Boller, F, Cappa, S, eds. Handbook of Neuropsychology, 2edn. Amsterdam: Elsevier Science. 2001:311–71.Google Scholar
42. Knopman, DS, Rocca, WA, Cha, RH, Eldman, SD, Kokmen, E. Incidence of vascular dementia in Rochester, Minn, 1985-1989. Arch Neurol. 2002;59:1605–10.CrossRefGoogle ScholarPubMed
43. Lopez, OL, Kuller, LH, Becker, JT, Jagust, WJ, DeKosky, ST, Fitzpatrick, A, et al. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology. 2005;64:1539–47.CrossRefGoogle ScholarPubMed
44. Bowler, JV. Vascular Cognitive impairment. J Neurol Neurosurg Psychiatry. 2005;76(Suppl V):v35–v44.CrossRefGoogle ScholarPubMed
45. O’Brien, JT, Erkinjuntti, T, Reisberg, B, Roman, G, Sawada, T, Pantoni, L, et al. Vascular cognitive impairment. Lancet Neurology. 2003; 2:89–98.CrossRefGoogle ScholarPubMed
46. Roman, G, Sachdev, P, Royall, DR, Bullock, RA, Oogogozo, JM, Lopez-Pousa, S, et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci. 2004;226:81–7.CrossRefGoogle ScholarPubMed
47. Sachdev, P. Vascular cognitive disorder. Int J Geriatr Psychiatry. 1999;14:402–3.3.0.CO;2-H>CrossRefGoogle ScholarPubMed
48. Erkinjuntti, T, Roman, G, Chui, H. Diagnostic criteria. In: Erkinjuntti, T, Gauthier, S, eds. Vascular cognitive impairment. London: Martin Dunitz 2002:43–58.Google ScholarPubMed
49. Rockwood, K, Black, SE, Song, X, Hogan, DB, Gauthier, S, Macknight, C, et al. Clinical and radiographic subtypes of vascular cognitive impairment in a clinic-based cohort study. J Neurol Sci. 2006; 240 (1–2):7–14.CrossRefGoogle Scholar
50. Rockwood, K, Bowler, J, Erkinjuntti, T, Hachinski, V, Wallin, A. Sub-types of vascular dementia. Alzheimer Dis Assoc Disord. 1999; 13 Suppl 3: S59–65.Google Scholar
51. World Health Organisation. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and diagnostic Guidelines. Geneva: World Health Organisation. 1992:50–1.Google Scholar
52. Chui, HC, Victoroff, JI, Margolin, D, Jagust, W, Shankle, R, Katzman, R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology. 1992;42:473–80.CrossRefGoogle ScholarPubMed
53. Roman, G, Tatemichi, TK, Erkinjuntti, T, the NINDS-AIREN Workgroup. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International workshop. Neurology. 1993; 43: 250–60.CrossRefGoogle ScholarPubMed
54. Rosen, WG, Terry, RD, Fuld, PA, Katzman, R, Peck, A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol. 1980; 7:486–8.CrossRefGoogle ScholarPubMed
55. Pantoni, L, Garcia, JH, Brown, GG. Vascular pathology in three cases of progressive cognitive deterioration. J Neurol Sci. 1996;135:131–9.CrossRefGoogle ScholarPubMed
56. Hulette, C, Nochlin, D, McKeel, DW, Morris, JC, Mirra, SS, Sumi, SM, et al. Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology. 1997;48:668–72.CrossRefGoogle ScholarPubMed
57. Wettering, T, Kanitz, RD, Borgis, KJ. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke. 1996;27:30–6.CrossRefGoogle Scholar
58. Crook, T, Bartus, RT, Ferris, SH, Whitehouse, P, Cohen, GD, Gershon, S. Age-associate memory impairment: proposed diagnostic criteria and measures of clinical changes: report of the National Institute of Mental Health Work Group. Dev Neuropsychol. 1986; 2:261–76.CrossRefGoogle Scholar
59. Ebly, EM, Hogan, DB, Parhad, I. Cognitive impairment in the non demented elderly. Results from the Canadian Study of Health and Aging (CSHA), Arch Neurol. 1995; 52:612–9.CrossRefGoogle Scholar
60. Levy, R. Aging-Associated cognitive Decline. Int Psychogeriatr. 1994; 6:63–68 Google ScholarPubMed
61. Feldman, HH, Jacova, C. Mild Cognitive impairment. Am J Geriatr Psychiatry. 2005; 13:645–55.CrossRefGoogle ScholarPubMed
62. Saxton, J, Lopez, OL, Ratcliff, G, Dulberg, C, Fried, LP, Carlson, MC. Preclinical Alzheimer disease: Neuropsychological test performance 1.5 to 8 years prior to onset. Neurology. 2004;63:2341–47.CrossRefGoogle ScholarPubMed
63. Morris, JC, Storandt, M, Miller, JP, Mckeel, DW, Price, JL, Rubin, EH. Mild cognitive impairment represents early-stage Alzheimer’s disease. Arch Neurol. 2001;58:397–405.CrossRefGoogle Scholar
64. Petersen, RC, Smith, GE, Waring, SC, Ivnik, RJ, Tangalos, EG, Kokmen, E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56: 303–8.CrossRefGoogle ScholarPubMed
65. Schröder, J, Kratz, B, Pantel, J, Minnemann, E, Lehr, U, Sauer, H. Prevalence of mild cognitive impairment in an elderly community sample. J Neural Transm. 1998 (Suppl.): 54: 51–9.Google Scholar
66. Loewenstein, DA, Acevedo, A, Argon, J, Issacson, R, Strauman, S, Crocco, E, et al. Cognitive profiles in Alzheimer’s disease and in mild cognitive impairment of different etiologies. Dement Geriatr Cogn Disord. 2006;21(5–6):309–15.CrossRefGoogle ScholarPubMed
67. Ribeiro, F, de Mendonca, A, Guerreiro, M. Mild cognitive impairment: deficits in cognitive domains other than memory. Dement Geriatr Cogn Disord. 2006;21(5–6):284–90.CrossRefGoogle ScholarPubMed
68. Petersen, RC, Doody, R, Kurz, A, Mohs, RC, Morris, JC, Rabins, PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001; 58:1985–92.CrossRefGoogle ScholarPubMed
69. Grundman, M., Petersen, RC, Morris, JC, Ferris, S, Sano, M, Farlow, MR, et al. Rate of dementia of Alzheimer type (DAT) in subjects with mild cognitive impairment: the Alzheimer’s Disease Cooperative Study (Abstract). Neurology. 1996; 46:A403.Google Scholar
70. Petersen, RC, Parisi, JE, Dickson, DW, Johnson, KA, Knopman, DS, Boeve, BF, et al. Neuropathological features of amnestic mild cognitive impairment. Arch Neurol. 2006; 63:665–72.CrossRefGoogle ScholarPubMed
71. Jicha, GA, Parisi, JE, Dickson, DW, Johnson, K, Cha, R, Ivnik, RJ, et al. Neuropathological outcome of mild cognitive impairment following progression to clinical Dementia. Arch Neurol. 2006;63:674–81.CrossRefGoogle ScholarPubMed